Article Details

LoA Update: Pfizer's binimetinib takes a 17-point hit to FDA approval prospects in AML due to ...

Retrieved on: 2021-04-28 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

LoA Update: Pfizer's binimetinib takes a 17-point hit to FDA approval prospects in AML due to .... View article details on HISWAI: https://www.clinicaltrialsarena.com/comment/loa-update-pfizers-binimetinib-takes-a-17-point-hit-to-fda-approval-prospects-in-aml-due-to-phase-ii-termination/

Excerpt

The likelihood of approval (LoA) for Pfizer's binimetinib in acute myeloid leukaemia (AML) plummeted 17 points on 21 April, according to GlobalData's ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up